Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Orthopaedics & Traumatology, Surgery & Research : OTSR|July 17, 2012
Rehabilitation implications during the development of the Norwich Enhanced Recovery Programme (NERP) for patients following total knee and total hip arthroplastyT O Smith, C McCabe, S Lister, et al.
Australian and New Zealand Journal of Public Health|February 5, 2002
February asthma outbreaks in NSW: a case control studyS Lister, V Sheppeard, G Morgan, et al.
Scandinavian Journal of Rheumatology|June 3, 2014
Living with osteoarthritis: a systematic review and meta-ethnographyT O Smith, R Purdy, S Lister, et al.
AIDS Research and Human Retroviruses|November 1, 1994
Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and CharacterizationR Cheingsong-Popov, S Lister, D Callow, et al.
The European Journal of Neuroscience|February 1, 1996
Acquisition of conditioned inhibition in rats is impaired by ablation of serotoninergic pathwaysS Lister, J M Pearce, S P Butcher, et al.
American Journal of Obstetrics and Gynecology|October 6, 2005
Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failuresMargit S Lister, Lynn E T Shaffer, Jeffrey G Bell, et al.
Neuropharmacology|August 1, 1983
The effects of acute and repeated administration of various antidepressant drugs on clonidine-induced hypoactivity in mice and ratsD J Heal, S Lister, S L Smith, et al.
International Journal of Fracture|March 28, 2025
High-velocity fragmentation of titanium alloy rings and cylinders produced using Field-Assisted Sintering TechnologyT Virazels, S Lister, O Levano-Blanch, et al.
BMC Health Services Research|November 7, 2015
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System PerspectiveM Charokopou, P McEwan, S Lister, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitusM Charokopou, P McEwan, S Lister, et al.
Pageof 5